Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: MEDP

Medpace Holdings, Inc.

Healthcare | Medical - Diagnostics & Research

No licensed closing price on file for MEDP. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$17.04

Medpace Holdings, Inc. (NASDAQ: MEDP) is a diagnostics and research company. Figures from SEC EDGAR; updated 2026-10-20 06:00 UTC.

What Medpace Holdings, Inc. does

This company is a clinical contract research organization that provides outsourced clinical development services to biotechnology, pharmaceutical, and medical device companies. It offers full-service Phase I-IV clinical trial support across multiple therapeutic areas, including Oncology, Metabolic, Cardiology, Antiviral, Anti-infective, and Central Nervous System disorders. The company delivers its services through specialized departments covering medical oversight, trial management, patient recruitment, clinical monitoring, regulatory affairs, data sciences, and laboratory testing.

Summarized from Medpace Holdings, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$17.04
Return on equity98.27%

Revenue, margins & earnings

FY2021 Net income: $182MFY2021 Operating costs: $944M$1.14BFY2021FY2022 Net income: $245MFY2022 Taxes & interest: $33MFY2022 Operating costs: $1.18B$1.46BFY2022FY2023 Net income: $283MFY2023 Taxes & interest: $54MFY2023 Operating costs: $1.55B$1.89BFY2023FY2024 Net income: $404MFY2024 Taxes & interest: $42MFY2024 Operating costs: $1.66B$2.11BFY2024FY2025 Net income: $451MFY2025 Taxes & interest: $84MFY2025 Operating costs: $2.00B$2.53BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-14
  • 2026-10-14Exec. VP, OperationsEmployee Stock Option (Right to Buy)Option exercise-3,000—
  • 2026-10-14Exec. VP, OperationsOption exercise3,000$500.2K
  • 2026-10-09Exec. VP, OperationsOption exercise2,000$333.5K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Medpace Holdings, Inc. do?

This company is a clinical contract research organization that provides outsourced clinical development services to biotechnology, pharmaceutical, and medical device companies.

When did MEDP last file with the SEC?

Medpace Holdings, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-04. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 06:00 UTC. This page is also available as JSON at /api/data?ticker=MEDP and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for MEDP and 5,000+ tickers.

Create a free account — keep MEDP
For your agent
GET /api/data?ticker=MEDP

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt